Exposure to antipsychotic medications over a 4-year period among children who initiated antipsychotic treatment before their sixth birthday

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00159816%3A_____%2F12%3A00060627" target="_blank" >RIV/00159816:_____/12:00060627 - isvavai.cz</a>

Výsledek na webu

<a href="http://dx.doi.org/10.1002/pds.2189" target="_blank" >http://dx.doi.org/10.1002/pds.2189</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1002/pds.2189" target="_blank" >10.1002/pds.2189</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Exposure to antipsychotic medications over a 4-year period among children who initiated antipsychotic treatment before their sixth birthday

Popis výsledku v původním jazyce

Purpose This study aims the following: (i) to describe the exposure to antipsychotic medications over a 4-year period experienced by a cohort of children who initiated antipsychotic treatment before their sixth birthday; and (ii) to identify variables associated with the risk of antipsychotic exposure. Methods Children were identified who initiated an index episode of antipsychotic treatment before their sixth birthday in Florida's fee for service Medicaid program. With the use of claims data, the medication utilization of these children was tracked during the year before and the 4 years following the start of their index episodes (pre-index and four post-index periods). Generalized estimating equations were used to identify variables associated with the risk of additional days of antipsychotic exposure. Results Five hundred twenty-eight children were included in the cohort. The mean total number of days of exposure was 821.9 (+/- 431.9), representing 56.3% of all days during the four

Název v anglickém jazyce

Exposure to antipsychotic medications over a 4-year period among children who initiated antipsychotic treatment before their sixth birthday

Popis výsledku anglicky

Purpose This study aims the following: (i) to describe the exposure to antipsychotic medications over a 4-year period experienced by a cohort of children who initiated antipsychotic treatment before their sixth birthday; and (ii) to identify variables associated with the risk of antipsychotic exposure. Methods Children were identified who initiated an index episode of antipsychotic treatment before their sixth birthday in Florida's fee for service Medicaid program. With the use of claims data, the medication utilization of these children was tracked during the year before and the 4 years following the start of their index episodes (pre-index and four post-index periods). Generalized estimating equations were used to identify variables associated with the risk of additional days of antipsychotic exposure. Results Five hundred twenty-eight children were included in the cohort. The mean total number of days of exposure was 821.9 (+/- 431.9), representing 56.3% of all days during the four

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FR - Farmakologie a lékárnická chemie

OECD FORD obor

—

Projekt

<a href="/cs/project/ED1.100%2F02%2F0123" target="_blank" >ED1.100/02/0123: Fakultní nemocnice u sv. Anny v Brně - Mezinárodní centrum klinického výzkumu (FNUSA - ICRC)</a><br>

Návaznosti

P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Rok uplatnění

2012

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Pharmacoepidemiology and drug safety

ISSN

1053-8569

e-ISSN

—

Svazek periodika

21

Číslo periodika v rámci svazku

2

Stát vydavatele periodika

US - Spojené státy americké

Počet stran výsledku

9

Strana od-do

152-160

Kód UT WoS článku

000299549600005

EID výsledku v databázi Scopus

—